Quick Summary
Biomab EGFR 200mg Injection
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹43079
MRP: ₹61541.17
(You Save ₹18462.17)
1 VIAL(s)
Biomab EGFR 200mg Injection
Salt Composition
NIMOTUZUMABMarketer
ERIS LIFESCIENCES LIMITED
Prepaid Only. Non-Returnable.
30% OFF
₹43079
MRP: ₹61,541.17
Inclusive of all taxes
30% Off
Salt Composition
NIMOTUZUMABMarketer
ERIS LIFESCIENCES LIMITED
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.


Introduction to Biomab EGFR 200mg Injection
Biomab EGFR 200mg Injection consists of the active Nimotuzumab. It is a monoclonal antibody used in cancer treatment. It has been approved for the treatment of head and neck cancer, as well as for certain types of brain cancer. This medication is typically used with other cancer treatments, such as chemotherapy and radiation therapy.
The Biomab egfr 200mg Injection effectively improves overall survival and disease-free survival in some cancer patients. However, like all cancer treatments, it can have side effects, including allergic reactions, skin rashes, and flu-like symptoms. transplant.
There are no absolute contraindications to Biomab EGFR 200mg Injection, but there are some precautions and potential contraindications to consider. For example, patients with a history of severe allergic reactions or hypersensitivity to it or its components should not receive the medication. Additionally, patients with certain medical conditions, such as severe liver or kidney disease, may need to be monitored closely or have their dosages adjusted.
Uses of Biomab EGFR 200mg Injection
Biomab EGFR 200mg Injection is used in the treatment of the following:
- Head and neck cancer
- Certain types of brain cancer
- Esophageal cancer
Therapeutic Effects of Biomab EGFR 200mg Injection
The therapeutic effect of Biomab EGFR 200mg Injection is primarily focused on its ability to target and bind to the epidermal growth factor receptor (EGFR) found on many cancer cells. Doing so can block the growth and spread of cancer cells, ultimately leading to improved patient outcomes. One of the advantages is its targeted therapy approach, which allows it to target cancer cells while minimising damage to healthy cells specifically. This can help to reduce side effects and improve the overall quality of life for cancer patients undergoing treatment.
Interaction of Biomab EGFR 200mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Biomab EGFR 200mg Injection and reduce effectiveness by causing undesirable side effects.
More Information about Biomab EGFR 200mg Injection
- Biomab EGFR 200mg Injection should be stored in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F).
- It does not need to be frozen, as this can damage its efficacy.
- Once a vial is opened, it should be used immediately.
- If inj Biomab is not used immediately, it can be stored at room temperature for 4 hours. After 4 hours, any remaining drug should be discarded.
- Keep out of reach of children and pets.
How to consume Biomab EGFR 200mg Injection
Biomab EGFR 200mg Injection is an injectable medication that a healthcare professional administers. It is typically given as an intravenous injection. The dose and frequency will depend on the type of cancer being treated, the patient's overall health, and other medications the patient may be taking. If you miss a dose, contact your healthcare provider as soon as possible. Your healthcare provider may recommend rescheduling your next dose or adjusting your dosing schedule. Do not double the dose to make a missed dose.
Safety Advice for Biomab EGFR 200mg Injection
Breast Feeding
There is limited information on whether Biomab EGFR 200mg Injection passes into breast milk, so it is important to talk to your healthcare provider before breastfeeding.
Alcohol
There are no known interactions between Biomab EGFR 200mg Injection and alcohol. So it is better to consult a healthcare provider.
Liver
Biomab EGFR 200mg Injection is primarily metabolised in the liver, so inform your healthcare provider if you have any liver problems or diseases. In some cases, it may cause liver toxicity, which can lead to elevated liver enzymes or other liver problems.
Lungs
If you have a pre-existing lung condition or disease, such as chronic obstructive pulmonary disease (COPD) or asthma, inform your healthcare provider before starting treatment. In some cases, it may cause lung toxicity, leading to symptoms such as cough, shortness of breath, wheezing, or chest pain.
Driving
Patients receiving Biomab EGFR 200mg Injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
Pregnancy
Biomab EGFR 200mg Injection is not safe for an unborn baby. Therefore, it is not recommended for pregnant women.
Side Effects of Biomab EGFR 200mg Injection
Like all medications, Biomab EGFR 200mg Injection can cause side effects, although not everyone who takes it will experience them.
Serious side effects of Biomab EGFR 200mg Injection are:
- Allergic reactions
- Difficulty breathing
- Swelling of the face or throat or hives
- Infusion reactions (fever, chills, or low blood pressure)
- Chest pain
- Irregular heartbeat
- Lung problems (cough or shortness of breath)
- Liver problems (jaundice or abdominal pain)
Common side effects of Biomab EGFR 200mg Injection are:
- Skin rash
- Diarrhea
- Nausea and vomiting
- Fatigue
- Headache
- Fever
- Pain at the injection site
Word of Advice
It is important to carefully read the medication label before taking Biomab EGFR 200mg Injection. Follow the instructions provided by your healthcare provider and the label, such as how much to take and how often. Your healthcare provider can provide more information on the risks and benefits of it and can help you determine if it is the right treatment option for you. It is important to report any side effects you may experience during treatment to your healthcare provider. Pregnancy and breastfeeding are not recommended while taking this medication. Before starting it or any other medication, inform your healthcare provider of any allergies or medications you are taking. This can help prevent any potential interactions or adverse effects.
FAQs about Biomab EGFR 200mg Injection
Q1.
Can Biomab EGFR 200mg Injection be used to prevent cancer?
Currently, Biomab EGFR 200mg Injection is only approved for cancer treatment, not prevention. However, ongoing research is investigating the potential role of this in cancer prevention and early detection.
Q2.
What food should I avoid while taking Biomab EGFR 200mg Injection?
There are no specific foods that you need to avoid while taking Biomab EGFR 200mg Injection. However, it is important to maintain a healthy and balanced diet to support your overall health and well-being during your cancer treatment.
Q3.
Is Biomab EGFR 200mg Injection causing hair fall?
Hair loss is not a common side effect of Biomab EGFR 200mg Injection treatment. However, some chemotherapy drugs often given in combination with this medication can cause hair loss as a side effect.
Q4.
What is the shelf life of Biomab EGFR 200mg Injection?
The shelf life of Biomab EGFR 200mg Injection can vary depending on the manufacturer and storage conditions. It is important to store the medication according to the instructions provided and to check the expiration date before use.
Q5.
Can Biomab EGFR 200mg Injection cure cancer?
Biomab EGFR 200mg Injection is not a cure for cancer, but it can be an effective treatment option for certain types of solid tumours. The effectiveness may vary depending on the stage and type of cancer being treated and individual factors.
Q6.
Can Biomab EGFR 200mg Injection cure cancer?
Biomab EGFR 200mg Injection is not a cure for cancer, but it can be an effective treatment option for certain types of solid tumours. The effectiveness may vary depending on the stage and type of cancer being treated and individual factors.
Q7.
Can Biomab EGFR 200mg Injection be combined with other cancer treatments?
Yes, Biomab EGFR 200mg Injection is often combined with other cancer treatments, such as chemotherapy and radiation therapy. Your doctor will determine the appropriate treatment regimen for your specific case.
Fact Box of Biomab EGFR 200mg Injection
| Molecule name: Nimotuzumab | Therapeutic class: Anticancer |
| Pharmacological class: Monoclonal Antibodies | Indications: 1. Head and neck cancer 2. Brain cancer 3. Esophageal cancer |
References
1. KD Tripathi, Essentials of Medical Pharmacology, 7th edition, Jaypee Brothers Medical Publishers (P) Ltd.; 2013, 893-894.
2. Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton, L.L., Chabner, B.A., and Knollmann, B.C., eds.). Biomab EGFR 200mg Injection. 13th edition, 1461-1463.
3. Bespons Pvt Ltd, U.S. Food and Drug Administration., Highlights of prescribing information - Biomab EGFR 200mg Injection, [Last updated: March 2020],[10 April 2023], Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761040s000lbl.pdf
4. S.H. Ibbotson, R.S. Dawe, Skin Disease, Davidson’s Principles & Practice of Medicine, 22nd Edition, 2014, 1249-1305
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vijayalakshmi N.
BDS

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)

Want to know more?
Read Our Editorial Policy








